Miguel Castanho
Miguel Castanho is a prominent researcher at the Institute of Molecular Medicine (IMM) at the University of Lisbon, known for his expertise in virology and infectious diseases. He has played a significant role in analyzing the evolution and impact of the SARS-CoV-2 virus during the COVID-19 pandemic, emphasizing the importance of vaccination and ongoing monitoring of variants. Recently, he was in the news discussing the reduced lethality of the coronavirus and the need for continued vaccination efforts, particularly among vulnerable populations.
Not in the pool (under ¢1).
Recent news mentions
Miguel Castanho received an honorable mention for his project integrating AI in protein design for breast cancer.
Rita Fior vence bolsa de investigação em oncologia no valor de 100 mil euros | Inteligência artificial
Portugal· 2025-06-25
Miguel Castanho is a biochemist who notes that ecological imbalances can favor new pandemics.
Mundo está mais perto do que nunca de um nova pandemia | SaúdePortugal· 2025-03-08
Miguel Castanho is a specialist at the Instituto de Medicina Molecular who discusses the evolution of the coronavirus and vaccination efforts in Portugal.
O coronavírus que paralisou o país — e o mundo — evoluiu e é agora menos letal | Covid-19Portugal· 2025-02-28